Welcome to Movers & Shakers, a roundup of the latest executive movements in the healthcare industry, featuring executive leadership changes at Jefferson Health, Genesis Health System and Roche Pharmaceuticals.

Use of the template, which included PCP notifications, also resulted in an increase of biochemical testing, follow-up imaging and specialist referrals in patients with incidental adrenal masses.

CEO turnover surged in the final months of 2022, indicating that the disruptive labor challenges that have defined this year may not be over.

The American Medical Association is asking Congress to step in before new Medicare payment cuts go into effect in 2023.

Women with dense breasts or other heightened risk factors for breast cancer may be on the cusp of receiving 100% coverage for additional imaging beyond standard mammography.

 The revisions impact insurers operating on the Affordable Care Act marketplace.

These notifications can sometimes leave many patients feeling even more bewildered about their mammogram results than they were before being made aware of their dense tissue.

The PHE has been in effect since the early days of the pandemic, and it has been reaffirmed every 90 days since. CMS has indicated it will give healthcare stakeholders at least 60 days’ notice before winding down the PHE.